Novartis Pharma
Global medicines company focused on discovery, development and delivery of therapies across small molecules, biologics, RNA, radioligand, gene and cell modalities. Operates integrated R&D platforms, clinical development and managed access programs, manufacturing and quality systems, and global access and sustainability initiatives.
Industries
Nr. of Employees
Very Large (1000+)
Patents
Compounds and compositions for treating conditions associated with STING activity
US-12503436-B2
View DetailsCrystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
US-12252478-B2
View Details
Compounds and compositions for treating conditions associated with STING activity
US-12503436-B2
View DetailsCrystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide
US-12252478-B2
View DetailsServices
Design and implementation of programs to provide access to therapies outside of standard clinical pathways.
Operational support for clinical trials including recruitment, site support and facilitation of investigator-initiated studies.
Process development, manufacturing scale-up and quality management activities to produce clinical and commercial supply.
Medical enquiry handling and adverse event reporting services supporting marketed products and clinical studies.
Design and implementation of programs to provide access to therapies outside of standard clinical pathways.
Operational support for clinical trials including recruitment, site support and facilitation of investigator-initiated studies.
Process development, manufacturing scale-up and quality management activities to produce clinical and commercial supply.
Medical enquiry handling and adverse event reporting services supporting marketed products and clinical studies.
Expertise Areas
- Clinical trial management
- Small-molecule discovery and medicinal chemistry
- Biologic therapeutic development
- RNA therapeutics
Key Technologies
- Small-molecule chemistry
- Antibody and protein biologics
- RNA therapeutics
- Gene therapy
News & Updates
Achieved A rating in CDP Climate Change and A rating in CDP Water Security (Double A List) in 2024.
Received a Reuters Responsible Business Award for the integrated report (Reporting and Transparency category).
Named among the Boston Consulting Group Top 50 Most Innovative Companies list.
Achieved A rating in CDP Climate Change and A rating in CDP Water Security (Double A List) in 2024.
Received a Reuters Responsible Business Award for the integrated report (Reporting and Transparency category).
Named among the Boston Consulting Group Top 50 Most Innovative Companies list.